VIRO logo

ViroGates A/S Stock Price

CPSE:VIRO Community·DKK 102.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

VIRO Share Price Performance

DKK 11.00
4.50 (69.23%)
DKK 11.00
4.50 (69.23%)
Price DKK 11.00

VIRO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with slight risk.

4 Risks
1 Reward

ViroGates A/S Key Details

DKK 8.9m

Revenue

DKK 2.3m

Cost of Revenue

DKK 6.6m

Gross Profit

DKK 17.0m

Other Expenses

-DKK 10.4m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 07, 2026
-1.12
74.36%
-116.77%
23.8%
View Full Analysis

About VIRO

Founded
2000
Employees
7
CEO
Jakob Knudsen
WebsiteView website
www.virogates.com

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma; suPARnostic AUTO Flex ELISA kit, a fully quantitative immunoassay designed for accurate and reliable measurement of soluble urokinase plasminogen activator receptor in human plasma; and suPARnostic Quick Triage, a test for rapid, quantitative measurement of suPAR levels. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.

Recent VIRO News & Updates

Recent updates

No updates